Chart Events
Performance Outlook
| Previous Close | 40.68 |
| Open | 40.66 |
| Bid | 40.12 x 1800 |
| Ask | 40.12 x 1800 |
| Day's Range | 39.95 - 40.67 |
| 52 Week Range | 29.99 - 43.08 |
| Volume | 20,608,147 |
| Avg. Volume | 27,618,190 |
| Market Cap | 224.747B |
| Beta (5Y Monthly) | 0.67 |
| PE Ratio (TTM) | 20.34 |
| EPS (TTM) | 1.97 |
| Earnings Date | Jul 26, 2021 - Jul 30, 2021 |
| Forward Dividend & Yield | 1.56 (3.89%) |
| Ex-Dividend Date | May 06, 2021 |
| 1y Target Est | 42.69 |
Fair Value
Related Research
- Insider Monkey
10 Best Money Saving Tips According to Experts
In this article we discuss the 10 best money saving tips according to experts. If you want to skip our detailed analysis of these tips, go directly to the 5 Best Money Saving Tips According to Experts. Saving money has become an uphill task for many average Americans amid flat wages, rising rents, astronomical healthcare […]
- Motley Fool
4 High-Yield Dividend Stocks to Watch
As of early June, an investor can earn roughly a 1.4% annual dividend yield by simply owning a market index fund that tracks the S&P 500. Read on to see why PepsiCo (NASDAQ: PEP), Hasbro (NASDAQ: HAS), IBM (NYSE: IBM), and Pfizer (NYSE: PFE) all deserve a spot on your income watchlist. Pepsi is just a year away from reaching Dividend King status, which will apply after it raises its dividend for a 50th consecutive year in 2022.
- Reuters
UPDATE 1-Vietnam approves Pfizer/BioNTech COVID-19 vaccine for emergency use
Vietnam has approved the COVID-19 vaccine jointly made by Pfizer and BioNTech for domestic emergency use, the government said on Saturday. Vietnam, which has previously approved the AstraZeneca vaccine, Russia's Sputnik V and China's Sinopharm vaccine, said it is seeking to procure 31 million doses of the Pfizer/BioNTech version for delivery in the next quarter. Vietnam is trying to accelerate its vaccine procurement drive to tackle a more stubborn wave of infections, even though its overall case load and fatality numbers remain relatively low.
